<strong>Background</strong><span style="font-family:Verdana;"><b>:</b></span><span style="font-family:Verdana;"> Myocardial ischemia is a dynamic process w...<strong>Background</strong><span style="font-family:Verdana;"><b>:</b></span><span style="font-family:Verdana;"> Myocardial ischemia is a dynamic process whereby a cascade of events is initiated to stimulate transition from reversible to irreversible cellular injury. Non-pharmacologic approaches to cellular protection, such as ische</span><span style="font-family:;" "=""><span style="font-family:Verdana;">mic conditioning, delay onset of cellular injury in most organs in a host of animal species;however the degree of protection is limited to rather short durations of ischemia. In the present study, we examined whether protection afforded by ischemic conditioning could be extended beyond currently established limits of coronary occlusion in an </span><i><span style="font-family:Verdana;">in situ</span></i><span style="font-family:Verdana;"> animal model.</span></span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;"><b>Methods</b></span><span style="font-family:Verdana;"><b>:</b></span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">Rabbits (n</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">=</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">106) were exposed to 30-, 60-, 120-, 180-, 240-, or 360-min coronary</span><span style="font-family:Verdana;"> </span><span style="font-family:;" "=""><span style="font-family:Verdana;">occlusion followed by 180-min coronary reperfusion (</span><i><span style="font-family:Verdana;">i</span></i><span style="font-family:Verdana;">.</span><i><span style="font-family:Verdana;">e</span></i><span style="font-family:Verdana;">. non-conditioned</span></span><span style="font-family:;" "=""><span style="font-family:Verdana;"> control groups). Ischemic conditioned rabbits were pre-treated by ischemic conditioning (</span><i><span style="font-family:Verdana;">i</span></i><span style="font-family:Verdana;">.</span><i><span style="font-family:Verdana;">e</span></i><span style="font-family:Verdana;">. 2-cycles of 5-min coronary occlusion and 5-min reperfusion) prior to a prolonged period of ischemia as described above. Area at risk (AR; by fluorescent microparticles) and area of necrosis (AN;by tetrazolium staining) were quantified by planimetry. Serum troponin I levels were assessed at baseline (</span><i><span style="font-family:Verdana;">i</span></i><span style="font-family:Verdana;">.</span><i><span style="font-family:Verdana;">e</span></i><span style="font-family:Verdana;">. before experimental protocol) and at the end of the experiment. </span></span><span style="font-family:;" "=""></span><span style="font-family:Verdana;"><b>Results</b></span><span style="font-family:Verdana;"><b>:</b></span><span style="font-family:;" "=""><span style="font-family:Verdana;"> Changes in heart rate and hemodyamic indices were similar for all groups regardless of duration of ischemia and regardless of treatment (</span><i><span style="font-family:Verdana;">i</span></i><span style="font-family:Verdana;">.</span><i><span style="font-family:Verdana;">e</span></i><span style="font-family:Verdana;">. non-conditioned vs. ischemic conditioned). Infarcts (as percent AR) were markedly smaller (~35%) in ischemic conditioned rabbits (vs. controls) for the 30-min coronary occlusion group. With longer durations of coronary occlusion (60</span></span><span style="font-family:Verdana;">-</span><span style="font-family:Verdana;">, 120-, 180-, 240-min) infarcts were smaller (~20%) in ischemic conditioned groups but protection afforded was not statistically significant. With 360-min coronary occlusion, infarct size was the same for both treatment groups. Serum troponin I levels were greater in relation to infarct size as expected but no differences were detected between treatments regardless of ischemic duration.</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;"><b>Conclusions</b></span><span style="font-family:Verdana;"><b>: </b></span><span style="font-family:Verdana;">Ischemic conditioning limits infarct development;however, protection is limited when the duration of ischemia is extended beyond 4 hours. These findings provide further support for the concept that ischemic conditioning can delay, but does not limit myocyte necrosis. Underlying mechanisms for cellular protection remain to be established.</span>展开更多
文摘<strong>Background</strong><span style="font-family:Verdana;"><b>:</b></span><span style="font-family:Verdana;"> Myocardial ischemia is a dynamic process whereby a cascade of events is initiated to stimulate transition from reversible to irreversible cellular injury. Non-pharmacologic approaches to cellular protection, such as ische</span><span style="font-family:;" "=""><span style="font-family:Verdana;">mic conditioning, delay onset of cellular injury in most organs in a host of animal species;however the degree of protection is limited to rather short durations of ischemia. In the present study, we examined whether protection afforded by ischemic conditioning could be extended beyond currently established limits of coronary occlusion in an </span><i><span style="font-family:Verdana;">in situ</span></i><span style="font-family:Verdana;"> animal model.</span></span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;"><b>Methods</b></span><span style="font-family:Verdana;"><b>:</b></span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">Rabbits (n</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">=</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">106) were exposed to 30-, 60-, 120-, 180-, 240-, or 360-min coronary</span><span style="font-family:Verdana;"> </span><span style="font-family:;" "=""><span style="font-family:Verdana;">occlusion followed by 180-min coronary reperfusion (</span><i><span style="font-family:Verdana;">i</span></i><span style="font-family:Verdana;">.</span><i><span style="font-family:Verdana;">e</span></i><span style="font-family:Verdana;">. non-conditioned</span></span><span style="font-family:;" "=""><span style="font-family:Verdana;"> control groups). Ischemic conditioned rabbits were pre-treated by ischemic conditioning (</span><i><span style="font-family:Verdana;">i</span></i><span style="font-family:Verdana;">.</span><i><span style="font-family:Verdana;">e</span></i><span style="font-family:Verdana;">. 2-cycles of 5-min coronary occlusion and 5-min reperfusion) prior to a prolonged period of ischemia as described above. Area at risk (AR; by fluorescent microparticles) and area of necrosis (AN;by tetrazolium staining) were quantified by planimetry. Serum troponin I levels were assessed at baseline (</span><i><span style="font-family:Verdana;">i</span></i><span style="font-family:Verdana;">.</span><i><span style="font-family:Verdana;">e</span></i><span style="font-family:Verdana;">. before experimental protocol) and at the end of the experiment. </span></span><span style="font-family:;" "=""></span><span style="font-family:Verdana;"><b>Results</b></span><span style="font-family:Verdana;"><b>:</b></span><span style="font-family:;" "=""><span style="font-family:Verdana;"> Changes in heart rate and hemodyamic indices were similar for all groups regardless of duration of ischemia and regardless of treatment (</span><i><span style="font-family:Verdana;">i</span></i><span style="font-family:Verdana;">.</span><i><span style="font-family:Verdana;">e</span></i><span style="font-family:Verdana;">. non-conditioned vs. ischemic conditioned). Infarcts (as percent AR) were markedly smaller (~35%) in ischemic conditioned rabbits (vs. controls) for the 30-min coronary occlusion group. With longer durations of coronary occlusion (60</span></span><span style="font-family:Verdana;">-</span><span style="font-family:Verdana;">, 120-, 180-, 240-min) infarcts were smaller (~20%) in ischemic conditioned groups but protection afforded was not statistically significant. With 360-min coronary occlusion, infarct size was the same for both treatment groups. Serum troponin I levels were greater in relation to infarct size as expected but no differences were detected between treatments regardless of ischemic duration.</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;"><b>Conclusions</b></span><span style="font-family:Verdana;"><b>: </b></span><span style="font-family:Verdana;">Ischemic conditioning limits infarct development;however, protection is limited when the duration of ischemia is extended beyond 4 hours. These findings provide further support for the concept that ischemic conditioning can delay, but does not limit myocyte necrosis. Underlying mechanisms for cellular protection remain to be established.</span>